The effect of oral Mycobacterium vaccae on subsequent responses of mice to BCG sensitization
Related Experiment Video
Updated: Aug 18, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Abstract:
It has been postulated that previous exposure to mycobacteria in the environment may be a contributing factor to the variable efficacy of BCG vaccination in protecting against human tuberculosis or leprosy, in different geographical regions. To test this hypothesis mice were given Mycobacterium vaccae in their drinking water for 3 weeks immediately, 27 days, or 54 days before they were injected subcutaneously with BCG. Spleen cells were examined, 50 days after injection of the mice, for ability to proliferate in vitro in response to killed mycobacteria added to the cultures. The results show that, depending on the timing of the exposure of the mice in vivo to M. vaccae before BCG injection and the dose of the mycobacterial challenge in vitro, oral administration of this species of environmental mycobacteria can either enhance, mask or interfere with the expression of sensitization by BCG. Thus, our data from mice support the hypothesis that the results of BCG vaccination for a particular human population are influenced by exposure to indigenous mycobacteria.
More Related Videos
07:14A CFSE-based Assay to Study the Migration of Murine Skin Dendritic Cells into Draining Lymph Nodes During Infection with Mycobacterium bovis Bacille Calmette-Guérin
Published on: October 9, 2016
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018